Martha Wadleigh
Elite in Myelofibrosis

Dr. Martha Wadleigh

Oncology | Hematology
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Adult Leukemia Program
450 Brookline Avenue, 
Boston, MA 
Offers Telehealth
Elite in Myelofibrosis
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Adult Leukemia Program
450 Brookline Avenue, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Martha Wadleigh is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Wadleigh is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Myelofibrosis, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 97 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles and participated in 1 clinical trial in the study of Myelofibrosis.

Graduate Institution
Duke University School Of Medicine, 1998
Residency
Duke University Medical Center-GME, 2001
Specialties
Oncology
Hematology
Licenses
Internal Medicine in MA
Board Certifications
Hematology
Internal Medicine
Medical Oncology
Fellowships
Dana-Farber/Partners CancerCare, 2004
Hospital Affiliations
Massachusetts General Hospital
Brigham And Women's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute, Adult Leukemia Program
450 Brookline Avenue, Boston, MA 02115
Call: 617-632-3712

Additional Areas of Focus

Dr. Wadleigh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Acute Myeloid Leukemia (AML)
Leukemia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Multi-center, Open-label, Randomized Study of Oral ABL001 Versus Bosutinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors
A Phase 3, Multi-center, Open-label, Randomized Study of Oral ABL001 Versus Bosutinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drugs: ABL001, Bosutinib
Study Phase: Phase 3
Tagraxofusp (SL-401) in Patients With Chronic Myelomonocytic Leukemia (CMML)
Tagraxofusp (SL-401) in Patients With Chronic Myelomonocytic Leukemia (CMML)
Enrollment Status: Completed
Publish Date: January 06, 2025
Intervention Type: Drug
Study Drug: Tagraxofusp
Study Phase: Phase 1/Phase 2
A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia
A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia
Enrollment Status: Completed
Publish Date: June 30, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

97 Total Publications

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
View All 97 Publications
Similar Doctors
Elite in Myelofibrosis
Dr. Gabriela S. Hobbs
Hematology Oncology | Hematology | Oncology
Elite in Myelofibrosis
Dr. Gabriela S. Hobbs
Hematology Oncology | Hematology | Oncology

The General Hospital Corporation

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-726-2000
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gabriela Hobbs is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Hobbs has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Hobbs is currently accepting new patients.

Daniel J. Deangelo
Distinguished in Myelofibrosis
Dr. Daniel J. Deangelo
Hematology Oncology | Hematology | Oncology
Distinguished in Myelofibrosis
Dr. Daniel J. Deangelo
Hematology Oncology | Hematology | Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Deangelo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Deangelo is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Deangelo is currently accepting new patients.

Richard M. Stone
Distinguished in Myelofibrosis
Dr. Richard M. Stone
Hematology Oncology | Hematology | Oncology
Distinguished in Myelofibrosis
Dr. Richard M. Stone
Hematology Oncology | Hematology | Oncology

Dana-Farber Cancer Institute, Adult Leukemia Program

450 Brookline Avenue, 
Boston, MA 
 (0.1 miles away)
617-632-2214
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Stone is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Stone is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

VIEW MORE MYELOFIBROSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wadleigh's expertise for a condition
ConditionClose
  • Elite
  • Acute Myeloid Leukemia (AML)
    Dr. Wadleigh is
    Elite
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Myelofibrosis
    Dr. Wadleigh is
    Elite
    . Learn about Myelofibrosis.
    See more Myelofibrosis experts
  • Distinguished
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Wadleigh is
    Distinguished
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Wadleigh is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Childhood Acute Myeloid Leukemia
    Dr. Wadleigh is
    Distinguished
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
  • Chronic Myelogenous Leukemia (CML)
    Dr. Wadleigh is
    Distinguished
    . Learn about Chronic Myelogenous Leukemia (CML).
    See more Chronic Myelogenous Leukemia (CML) experts
  • Essential Thrombocythemia
    Dr. Wadleigh is
    Distinguished
    . Learn about Essential Thrombocythemia.
    See more Essential Thrombocythemia experts
  • Leukemia
    Dr. Wadleigh is
    Distinguished
    . Learn about Leukemia.
    See more Leukemia experts
View All 10 Distinguished Conditions
  • Advanced
  • Acute Eosinophilic Pneumonia
    Dr. Wadleigh is
    Advanced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Wadleigh is
    Advanced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myelomonocytic Leukemia
    Dr. Wadleigh is
    Advanced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Acute Promyelocytic Leukemia
    Dr. Wadleigh is
    Advanced
    . Learn about Acute Promyelocytic Leukemia.
    See more Acute Promyelocytic Leukemia experts
  • Bone Marrow Aspiration
    Dr. Wadleigh is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Chronic Myelomonocytic Leukemia (CMML)
    Dr. Wadleigh is
    Advanced
    . Learn about Chronic Myelomonocytic Leukemia (CMML).
    See more Chronic Myelomonocytic Leukemia (CMML) experts
View All 12 Advanced Conditions
  • Experienced
  • Acute Monoblastic Leukemia (AmoL)
    Dr. Wadleigh is
    Experienced
    . Learn about Acute Monoblastic Leukemia (AmoL).
    See more Acute Monoblastic Leukemia (AmoL) experts
  • Agranulocytosis
    Dr. Wadleigh is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anemia
    Dr. Wadleigh is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Aplastic Anemia
    Dr. Wadleigh is
    Experienced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Blood Clots
    Dr. Wadleigh is
    Experienced
    . Learn about Blood Clots.
    See more Blood Clots experts
  • Bone Marrow Transplant
    Dr. Wadleigh is
    Experienced
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.